Scoop: Just months after Sanofi AI deal, Atomwise laid off 30% of staffers amid ‘strategic shift’

Atomwise, a well-connected player in the burgeoning space of artificial intelligence-powered drug discovery, cut its headcount by 30% in December, Endpoints News has learned.

Abraham Heifets

CEO and co-founder Abraham Heifets confirmed the layoffs, which resulted in around 30 people departing the company.

“We had...

Click to view original post